Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
申请人:Enanta Pharmaceuticals, Inc.
公开号:US10208081B2
公开(公告)日:2019-02-19
The present invention provides compounds of Formula I,
pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
本发明提供了式 I 的化合物、
包含这些化合物的药物组合物,以及使用这些化合物预防或治疗 FXR 介导或 TGR5 介导的疾病或病症的方法。
Biocatalytic <i>N</i>-Alkylation of Amines Using Either Primary Alcohols or Carboxylic Acids via Reductive Aminase Cascades
作者:Jeremy I. Ramsden、Rachel S. Heath、Sasha R. Derrington、Sarah L. Montgomery、Juan Mangas-Sanchez、Keith R. Mulholland、Nicholas J. Turner
DOI:10.1021/jacs.8b11561
日期:2019.1.23
The alkylation of amines with either alcohols or carboxylic acids represents a mild and safe alternative to the use of genotoxic alkyl halides and sulfonate esters. Here we report two complementary one-pot systems in which the reductive aminase (RedAm) from Aspergillus oryzae is combined with either (i) a 1° alcohol/alcohol oxidase (AO) or (ii) carboxylic acid/carboxylic acid reductase (CAR) to affect